Newborn Screening Program

The NSW and ACT newborn screening program has been expanded to include genetic diseases Spinal Muscular Atrophy (SMA) and Primary Immunodeficencies (PID) as part of a two-year pilot study. The new screening program has been funded by the NSW government and coordinated through Paediatrio.

Early detection of these rare and life-threatening conditions will improve access to clinical trials and early treatment, even before symptoms arise and cause serious health complications.  

© 2016 Paediatrio